Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01536873 · ClinicalTrials.gov registry record · NA
Dolutegravir Expanded Access Study
A NA study, sponsored by ViiV Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT01536873 is a NA study that has completed, run by ViiV Healthcare. The registered enrollment target is 200 participants.
The verdict
NCT01536873, a NA study, has completed, sponsored by ViiV Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
ING114916 is an open-label, multi-center, expanded access (EAP) study
Interventions
- DRUG Dolutegravir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-06-14 |
| Est. Completion | 2016-09-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01536873
The ClinicalTrials.gov registry entry for NCT01536873 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ViiV Healthcare, which has 182 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dolutegravir is the first listed.
NCT01536873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01536873 about?
NCT01536873 is a clinical study titled "Dolutegravir Expanded Access Study". ING114916 is an open-label, multi-center, expanded access (EAP) study
What is the current status of trial NCT01536873?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2012-06-14. Estimated completion is 2016-09-23.
What interventions are being tested in trial NCT01536873?
The interventions under investigation include: Dolutegravir (DRUG).
Who is sponsoring clinical trial NCT01536873?
This trial is sponsored by ViiV Healthcare, which has 182 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.